longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Accelerate Diagnostics

AXDX

0.03400.00% ( 0.0000 )
Delay Suspended: Sep 9, 09:05:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • ABL Diagnostics: Availability of the 2025 Annual Financial Report

    MorningStar·May 7 at 10:15 PM
    BJDX-2.91%AXDX0.00%
  • Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test

    Tip Ranks·Mar 31 at 12:44 AM
    AXDX0.00%FBT-0.12%
  • Cleo Diagnostics Selects Next-Generation Ella Platform to Deliver Ovarian Cancer Blood Test

    Small Caps·Feb 18 at 02:06 AM
    TECH-0.06%CODX+1.34%